Literature DB >> 17343579

Epidemiology of pemphigus in Macedonia: a 15-year retrospective study (1990-2004).

Marija T V'lckova-Laskoska1, Dimitri S Laskoski, Suzana Kamberova, Nina Caca-Biljanovska, Nadja Volckova.   

Abstract

BACKGROUND: Pemphigus is an autoimmune blistering skin disease mediated by auto-antibodies directed against desmoglein proteins. There are only a few epidemiological studies on pemphigus. Our objective was to determine the epidemiological features of pemphigus in Macedonia, and to compare the results with those reported elsewhere.
METHODS: Diagnosis in all cases was confirmed by histopathology and direct immunofluorescence. Binomial distribution testing and Fisher's exact-test at the 0.01 level of significance were used to determine if particular demographic groups were over-/ under-represented among the pemphigus patients.
RESULTS: One hundred and thirty-three new pemphigus cases were diagnosed in Macedonia from 1990-2004. The average annual incidence was 0.44/100,000 inhabitants (SD = 0.17). The incidence doubled to 0.89 in 2001 during the local armed unrest. The disease did not affect either gender to a greater extent. The average annual incidence was 0.51 for ethnic Macedonians. Roma (Gypsies) had a statistically significantly higher incidence of pemphigus at 2.4 cases/100,000 individuals. Ethnic Albanians had statistically significantly lower incidence of 0.1 cases/100,000 individuals. The most common variant was pemphigus vulgaris (77.4%).
CONCLUSIONS: The annual incidence for pemphigus in Macedonia is 0.44 cases/100,000 inhabitants. Most common form was pemphigus vulgaris. An epidemiological peak occurred in 2001 during the local armed conflict. Macedonian Roma had a sixfold higher incidence of pemphigus compared with the overall population; ethnic Albanians had a fourfold lower incidence.

Entities:  

Mesh:

Year:  2007        PMID: 17343579     DOI: 10.1111/j.1365-4632.2006.03010.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  A rare presentation of pemphigus vulgaris as multiple pustules.

Authors:  Yang Yang; Min Lin; Su Jiang Huang; Chen Min; Wan Qing Liao
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

Review 2.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

Review 3.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 4.  Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

Authors:  Hanan Rashid; Aniek Lamberts; Gilles F H Diercks; Hendri H Pas; Joost M Meijer; Maria C Bolling; Barbara Horváth
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

5.  Incidence of Bullous Pemphigoid and Pemphigus in Korea.

Authors:  Jae Seong Joo; Sook Jung Yun; Seung-Chul Lee; Jee-Bum Lee
Journal:  Ann Dermatol       Date:  2021-03-08       Impact factor: 1.444

Review 6.  Epidemiology of Pemphigus.

Authors:  Khalaf Kridin; Enno Schmidt
Journal:  JID Innov       Date:  2021-02-20

7.  Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population.

Authors:  Kossara Drenovska; Milena Ivanova; Snejina Vassileva; Martin Abu Shahid; Elissaveta Naumova
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

8.  Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.

Authors:  S M Langan; L Smeeth; R Hubbard; K M Fleming; C J P Smith; J West
Journal:  BMJ       Date:  2008-07-09

9.  A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

Authors:  Zekayi Kutlubay; Ayşegül Sevim Keçici; Uğur Çelik; Mehmet Cem Mat
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.